会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • SCLERAL PROSTHESIS FOR TREATING PRESBYOPIA AND OTHER EYE DISORDERS AND RELATED DEVICES AND METHODS
    • 治疗前列腺炎和其他眼病的SCLERAL PROSTHESIS及相关设备和方法
    • US20110077735A1
    • 2011-03-31
    • US12960917
    • 2010-12-06
    • Jack C. Griffis, III
    • Jack C. Griffis, III
    • A61F2/16
    • A61F2/147A61F2/148A61F2210/0023
    • One example scleral prosthesis includes a first free end and a second free end, each wider than a middle portion of the scleral prosthesis. Multiple first portions form the first end of the scleral prosthesis. The first portions are separated along at least half of a length of the scleral prosthesis. Multiple second portions may form the second end of the scleral prosthesis, and the second portions may be separated along less than a quarter of the length of the scleral prosthesis. An implantation device can be used to facilitate implantation of a scleral prosthesis. The implantation device includes a first end portion configured to be inserted into a scleral tunnel of an eye. The implantation device also includes a second end portion configured to receive the scleral prosthesis. A rod with a tapered and rounded end can be partially inserted into the first end portion of the implantation device.
    • 一个例子是巩膜假体包括第一自由端和第二自由端,每个宽度大于巩膜假体的中间部分。 多个第一部分形成巩膜假体的第一端。 第一部分沿巩膜假体长度的至少一半分开。 多个第二部分可以形成巩膜假体的第二端,并且第二部分可以沿着巩膜假体的长度的小于四分之一分开。 可以使用植入装置来促进巩膜假体的植入。 植入装置包括构造成插入到眼睛的巩膜隧道中的第一端部。 植入装置还包括构造成接收巩膜假体的第二端部。 具有锥形和圆形端的杆可以部分地插入植入装置的第一端部。
    • 4. 发明申请
    • Method and system for maintaining aseptic conditions in the storage of biologics
    • 维持生物制品储存无菌条件的方法和系统
    • US20110054436A1
    • 2011-03-03
    • US12806541
    • 2010-08-16
    • Jack C. Griffis, IIIMinh Vo
    • Jack C. Griffis, IIIMinh Vo
    • A61J1/22
    • A61J1/2096A61J1/2037A61J9/00
    • Technologies are generally described for the storage of biologics and other fluid materials while maintaining aseptic conditions. A system may include a storage body providing a reservoir for containing the materials. A cap may couple to the storage body forming a fluid-tight seal. A port may be provided for transferring the materials. A seal, or valve, may be provided within the port. The seal may be configured to close off the reservoir unless acted upon to release the materials through the port. A movable member may make up part of the storage body. The movable member may be configured to change a reservoir volume of the storage body in response to changes in a volume of the materials. The reservoir may become smaller as the materials are released. Multi-dose volumes of fluid materials may be stored for repeated access with reduced risk of contamination and reduction in shelf life.
    • 技术通常被描述为用于储存生物制剂和其它流体材料,同时保持无菌条件。 系统可以包括提供用于容纳材料的储存器的存储体。 盖可以连接到存储体,形成流体密封。 可以提供用于传送材料的端口。 密封件或阀门可以在端口内提供。 密封件可以被配置为关闭储存器,除非作用于通过端口释放材料。 可移动部件可以构成存储体的一部分。 可移动构件可以被配置为响应于材料体积的变化而改变存储体的储存器容积。 当材料被释放时,储存器可能变小。 多剂量的流体材料可以被存储以用于重复进入,降低污染的风险和降低保质期。
    • 7. 发明授权
    • Guided delivery of cell, particle, and drug based therapies
    • 引导细胞,颗粒和药物治疗的传递
    • US08535291B1
    • 2013-09-17
    • US13466041
    • 2012-05-07
    • Raymond P. VitoJack C. Griffis, IIIW. Robert TaylorMichael L. Wach
    • Raymond P. VitoJack C. Griffis, IIIW. Robert TaylorMichael L. Wach
    • A61M31/00
    • A61B17/3478A61B2017/00243A61B2017/00247A61B2034/102G06F19/00
    • A medical practitioner can specify certain parameters for a procedure that involves delivering a therapeutic agent, while leaving other parameters open. The therapeutic agent can be sensitive to biomechanical forces (or other influences) associated with delivery. The procedure can involve regenerative medicine, for example delivering progenitor or stem cells to a diseased heart using a catheter, whereby unbridled transport in the catheter may compromise efficacy. The open parameters can influence efficacy of the agent and thus therapeutic outcome. A computer-based system can apply stored information, such as from databases, to narrow the possible values of the open parameters. From the narrowed possibilities, an optimization routine can determine suitable or optimized values for the open parameters. The determined values can manage biomechanical forces incurred by the therapeutic agent, thereby promoting efficacy and healing. The optimized parameters can guide the practitioner in the procedure.
    • 医生可以指定涉及递送治疗剂的过程的某些参数,同时留下其他参数。 治疗剂可以对与递送相关的生物力学力(或其他影响)敏感。 该过程可以涉及再生医学,例如使用导管将祖细胞或干细胞递送到患病心脏,由此在导管中的肆无忌惮的运输可能损害功效。 开放参数可以影响药剂的疗效,从而影响治疗效果。 基于计算机的系统可以应用诸如数据库之类的存储信息来缩小开放参数的可能值。 从缩小的可能性,优化程序可以确定开放参数的合适或优化的值。 确定的值可以管理治疗剂引起的生物力学力,从而促进功效和愈合。 优化的参数可以指导实践者在程序中。